Arumugam Muruganandam

This inventor holds 10 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Merrimack Pharmaceuticals, Inc., Dyax Corporation, National Research Council of Canada. Active years: 2010-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arumugam Muruganandam. Retrieved from https://idiyas.com/inventor/arumugam-muruganandam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 13)

% Patents Active = 70.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 175(Granted Patents)

Company Filing History:

4 out of 54

Merrimack Pharmaceuticals, Inc.

National Research Council of Canada

patents

4. 2 out of 14

Syntonix Pharmaceuticals, Inc.

patents

5. 1 out of 2

Biogen Hemophilia Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2016

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9487588 - Antibodies against the ectodomain of ERBB3 and uses thereof (2016-11-08),

2. 9260520 - Antibodies to FeRn and uses thereof (2016-02-16),

3. 8961966 - Antibodies against ERBB3 and uses thereof (2015-02-24),

4. 8815246 - Fc receptor binding proteins (2014-08-26),

5. 8715659 - Single domain brain-targeting antibody fragments derived from llama antibodies (2014-05-06),

6. 8691225 - Antibodies against the ectodomain of ErbB3 and uses thereof (2014-04-08),

7. 8383107 - Single domain brain-targeting antibody fragments derived from llama antibodies (2013-02-26),

8. 8273351 - Fc receptor binding proteins (2012-09-25),

9. 7943129 - Single-domain brain-targeting antibody fragments derived from llama antibodies (2011-05-17),

10. 7846440 - Antibodies against ErbB3 and uses thereof (2010-12-07),

Title: Arumugam Muruganandam: A Visionary Inventor Shaping the Future of Biotechnology

Introduction:

Arumugam Muruganandam, a visionary inventor based in Bengaluru, India, has made significant contributions to the world of biotechnology through his relentless pursuit of innovation. With a passion for creating solutions to complex challenges, he has solidified his reputation as a pioneering inventor whose work continues to inspire future generations.

Latest Patents:

Among his impressive portfolio of patents, Arumugam Muruganandam's latest inventions include groundbreaking discoveries in antibody technology. "Antibodies against the ectodomain of ERBB3 and uses thereof" offer a novel class of antibodies and antigen binding fragments that inhibit various functions of the ErbB3 receptor, showing promise in inhibiting cancer cell proliferation. Additionally, his patent on "Antibodies to FeRn and uses thereof" introduces proteins that bind to FcRn, offering potential treatments for autoimmune disorders.

Career Highlights:

Arumugam Muruganandam has made notable contributions during his time at renowned companies such as Merrimack Pharmaceuticals, Inc. and the National Research Council of Canada. His expertise and innovative approach have propelled advancements in biotechnology, leading to the development of cutting-edge solutions that address crucial medical challenges.

Collaborations:

Throughout his career, Arumugam Muruganandam has collaborated with esteemed professionals in the field, including Birgit Schoeberl and Ulrik Bjerl Nielsen. These collaborations have fostered a dynamic environment for sharing knowledge, exchanging ideas, and driving forward innovative projects that have the potential to make a lasting impact on the biotechnology industry.

Conclusion:

In conclusion, Arumugam Muruganandam's visionary spirit and dedication to pushing the boundaries of biotechnology have established him as a trailblazer in the field of invention. His patents not only showcase his technical expertise but also reflect his commitment to addressing critical medical needs through innovative solutions. As he continues to inspire future inventors, his legacy serves as a testament to the power of innovation in shaping a brighter future for the world of patents and inventions.

Profile summary based on public USPTO records.